Detalles de la búsqueda
1.
Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 105-115.e14, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32950748
2.
Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection.
J Antimicrob Chemother
; 77(4): 1102-1110, 2022 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35040959
3.
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
Gastroenterology
; 158(3): 537-549.e10, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31493397
4.
Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosis.
Antimicrob Agents Chemother
; 63(12)2019 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31570394
5.
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B.
Hepatol Commun
; 6(12): 3457-3472, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36194181
6.
Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects.
PLoS One
; 13(10): e0204974, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30325939
Resultados
1 -
6
de 6
1
Próxima >
>>